Pharmafile Logo

Darley Limited

Darley is one of the UK’s most famous names in specialised printing solutions, such as wet glue labels. It’s also the largest producer of bottle labels in the country. Appropriately enough, Darley is based at the heart of the brewing industry in Burton upon Trent, Staffordshire. In short, Darley’s the name behind big names, making brands work.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Wellington Road, Burton upon Trent, Staffordshire, DE14 2AD, United Kingdom
+44 (0)1283 564 936

 Latest Content from PMHub 

Lucid CEO discusses his inspiration and passion for changing patients’ lives

Changing patients' lives with innovative methodologies in medical education

Infographic: Spondyloarthritis

Overview of spondyloarthritis patient profiles and treatment pathways.

Webinar: Demand assessment – Reflecting real world choices

How study design which reflects doctors’ real world choices can optimise results.

Evaluating the potential of a pre-launch prodct in a real-life setting

Using in-depth-interviews as well as a SmartPhone app to collect real patient cases from physicians to find out opportunity for a new product.

Blue Latitude Health shortlisted for two PMEA 2015 awards

Blue Latitude Health’s Medical Information Cascade project for Eli Lilly and Company has been shortlisted in the Excellence in Physicians/Healthcare Provider Support Programmes and Innovation categories.

10 tips for developing insightful pre-launch positioning

By getting your positioning right, you can build the motivational, aspirational, and resonant brand story and messaging that will allow your product to become a brand. Blue Latitude Health's Head...

Bigger than brand: Portfolio Positioning for Pharma

Senior Consultant Jenna Earl talks us through the three most important things to understand about portfolio positioning in pharma.

Tackling biosimilars – how to handle the threat to Pharma brands

Strategy Consultant Mark Assenti outlines three key points for developing a strategy to tackle the threat to Pharma brands from biosimilars.